Skip to content

Raltegravir EP Impurity D

Raltegravir EP Impurity D

Product Description
CAT No.
ALN-R009004
CAS No.
1064706-98-4
Mol. F.
C18H19FN4O6
Mol. Wt.
406.4
Stock
Please Inquire
Chemical Name : [[2-[4-[[(4-fluorophenyl)methyl]carbamoyl]-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl]propan-2-yl]amino]oxoacetic acid (as per EP)
Smiles : O=C(O)C(NC(C)(C1=NC(C(NCC2=CC=C(F)C=C2)=O)=C(O)C(N1C)=O)C)=O
Inchi : InChI=1S/C19H24FN5O3/c1-19(2,22-11-24(3)4)18-23-14(15(26)17(28)25(18)5)16(27)21-10-12-6-8-13(20)9-7-12/h6-9,11,26H,10H2,1-5H3,(H,21,27)/b22-11+
Synonym : Raltegravir Oxalyl Analog

Development and validation of stability indicating RP-HPLC assay method of raltegravir in tablet dosage forms

By Shirisha, V.; Sairaju, B.; Illendula, Santhosh; Dutt, K. RajeswarnFrom World Journal of Pharmacy and Pharmaceutical Sciences (2019), 8(10), 668-692

Stability indicating reverse-phase high performance liquid chromatography method for the determination of raltegravir in bulk and pharmaceutical formulation

By Annapurna, Mukthinuthalapati Mathrusri; Teja, Gunnam Ravi; Hemchand, S.; Babu, R. Ravi Chandra – From International Journal of Green Pharmacy (2018), 12(1Suppl.), S177-S180

Development and validation of RP-HPLC method for determination of raltegravir and its impurities in bulk drug and dosage forms

By Balaji, M.; AppaRao, K. M. Ch.; Ramakrishna, K.; Srinivasarao, V. – From Pharma Science Monitor (2014), 5(3Suppl.1), 187-196, 10 pp.

Request For Quotation